{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:52:12Z","timestamp":1760147532565,"version":"3.37.3"},"reference-count":13,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1136\/archdischild-2018-315498","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T16:24:54Z","timestamp":1531585494000},"page":"907.1-909","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?"],"prefix":"10.1136","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4701-3813","authenticated-orcid":false,"given":"Joseph","family":"Moneim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,7,14]]},"reference":[{"key":"2020050712450717000_103.9.907.1","doi-asserted-by":"publisher","DOI":"10.1097\/DMP.0b013e318158c5fd"},{"key":"2020050712450717000_103.9.907.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197609302951407"},{"key":"2020050712450717000_103.9.907.3","first-page":"1388","article-title":"Infant botulism","volume":"65","author":"Cox","year":"2002","journal-title":"Am Fam Physician"},{"key":"2020050712450717000_103.9.907.4","doi-asserted-by":"publisher","DOI":"10.1086\/444507"},{"key":"2020050712450717000_103.9.907.5","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05261-11"},{"key":"2020050712450717000_103.9.907.6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90469-6"},{"key":"2020050712450717000_103.9.907.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051926"},{"key":"2020050712450717000_103.9.907.8","doi-asserted-by":"crossref","unstructured":"Chalk CH , Benstead TJ , Keezer M . Medical treatment for botulism. Cochrane Database Syst Rev 2014:CD008123. CD008123. doi.doi:10.1002\/14651858.CD008123.pub3","DOI":"10.1002\/14651858.CD008123.pub3"},{"key":"2020050712450717000_103.9.907.9","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807308707"},{"key":"2020050712450717000_103.9.907.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3276"},{"key":"2020050712450717000_103.9.907.11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pediatrneurol.2008.05.001","article-title":"Infant botulism type Ba: first culture-confirmed case in the United Arab Emirates","volume":"39","author":"Fathalla","year":"2008","journal-title":"Pediatr Neurol"},{"key":"2020050712450717000_103.9.907.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2013.05.017"},{"key":"2020050712450717000_103.9.907.13","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268814002672"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-315498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:14:14Z","timestamp":1601072054000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-315498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,14]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,16]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/archdischild-2018-315498"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-315498","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2018,7,14]]}}}